Tag: MOBILE trial
Cell therapy may provide benefit for “no option” critical limb ischaemia...
Two-year results from the MOBILE (Marrowstim treatment of limb ischaemia in patients with severe peripheral arterial disease) trial indicate that injecting concentrated bone marrow...
Autologous bone marrow cell injection reduces one-year amputation rate for Rutherford...
Fifty-two-week outcomes of the MOBILE trial indicate a “significant reduction in major amputations” among Rutherford 4 and non-diabetic Rutherford 5 critical limb ischaemia patients...
